Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/15/1996CN1122224A Pharmaceutical with anti-high-blood-sugar function
05/15/1996CN1122223A Preparing method for program-controlled skin permeable plaster
05/15/1996CN1031795C Process for preparing
05/15/1996CA2162760A1 Immunosuppressive cyclolignan derivatives
05/15/1996CA2162739A1 Fortified milk
05/15/1996CA2135687A1 Method for the treatment and/or prevention of radiation burn
05/14/1996US5516941 Oxidizing 3-aminobenzamide to 3-nitrosobenzamide; viricides; anticarcinogenic and antitumor agents
05/14/1996US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
05/14/1996US5516936 Inhibitors of kynureninase
05/14/1996US5516925 Amino acid chelates having improved palatability
05/14/1996US5516910 Ticlopidine intermediate
05/14/1996US5516908 1,3-dihydro-2H-imidazo-[4,5-β]quinolin-2-one derivatives and intermediates
05/14/1996US5516907 Antiinflammatory agents
05/14/1996US5516905 Enzyme inhibitors of dna polymerase for bactericides
05/14/1996US5516807 Administering a polyamine to a patient to treat or prevent restenosis
05/14/1996US5516806 Ornithine decarboxylase inhibiting cyclic aminooxy compounds
05/14/1996US5516805 Antiischemic agents, anticarcinogenic agents and antiarrhythmia agents for cardiovascular disorders
05/14/1996US5516803 Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
05/14/1996US5516801 Preventing kidney stones
05/14/1996US5516800 Administering combination of arachidonic and docosahexaenoic acids
05/14/1996US5516799 Method of treating small mouth ulcers
05/14/1996US5516798 Administering a methylamine
05/14/1996US5516797 Suppressing graft rejection
05/14/1996US5516796 Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
05/14/1996US5516793 Use of ascorbic acid to reduce irritation of topically applied active ingredients
05/14/1996US5516792 Anticarcinogenic agents
05/14/1996US5516791 7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereof
05/14/1996US5516785 Anabaseine, stimulating brain cholinergic transmission
05/14/1996US5516784 Anti-HIV (AIDS) agents
05/14/1996US5516783 Platelet activating factor
05/14/1996US5516781 Method of treating restenosis with rapamycin
05/14/1996US5516780 Immunosuppressive, antiinflammatory, antifungal and antitumor agents
05/14/1996US5516778 Method for improving tissue antioxidant status
05/14/1996US5516775 Further use of pyrimidine derivatives
05/14/1996US5516774 Treating diseases characterized by excess renal reabsorption of water
05/14/1996US5516773 Agent for treating high blood pressure and cardiac insufficiency
05/14/1996US5516772 K-252 derivatives which enhance neurotrophin-induced activity
05/14/1996US5516771 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
05/14/1996US5516770 Rapamycin formulation for IV injection
05/14/1996US5516769 Administering an antiprogestin to prevent ovulation or interfere with the menstrual cycle of a mammal
05/14/1996US5516768 Uncompetitive inhibition of steroid and 5α-reductose
05/14/1996US5516766 Proteins adsorbed on cyclodextrins, such as heparin binding growth factor, fibroblast growth factor for polyionic derivatives
05/14/1996US5516765 Therapeutic method for the treatment or prevention of snoring
05/14/1996US5516764 Anti-inflammatory agent
05/14/1996US5516763 For total or partial replacement of sucrose in dietetics; specified limits of latiice cell constants, melting range and water content
05/14/1996US5516758 Polyamides bearing functionalized side chains useful as water soluble hypolipidemic agents
05/14/1996US5516684 Biologically pure culture of Lactobacillus acidophilus FERM-P-14204 or FERM-P-14205
05/14/1996US5516653 Genetic engineering
05/14/1996US5516631 Method of inhibiting replication of hyperproliferative cells
05/14/1996US5516528 Dietary phytoestrogen in estrogen replacement therapy
05/14/1996US5516526 Compositions containing DMSO and Fructose 1,6-diphosphate
05/14/1996US5516525 Vitamin D derivative feed compositions and methods of use
05/14/1996US5516524 Dioctylsulfosuccinate
05/14/1996US5516510 Deodorizing active ingredients
05/14/1996CA2094090C Thixotropic formulations
05/14/1996CA2088273C Processes for formulating a solid oral dosage form of loperamide compounds
05/14/1996CA2069917C Carnitine supplemented cat fish diet
05/14/1996CA1338326C Compounds for the treatment of alzheimer's disease
05/14/1996CA1338325C Pharmaceutical composition and method of use
05/11/1996CA2135669A1 Ribavirin as hepato (liver) protecting agent
05/10/1996CA2162342A1 Intravenous solutions for a derivative of staurosporine
05/10/1996CA2162341A1 Pharmaceutical carriers
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013512A2 L-ribofuranosyl nucleosides
05/09/1996WO1996013507A1 Synthetic polyunsaturated fatty acid analogues
05/09/1996WO1996013506A1 Protein kinase inhibitors for treatment of neurological disorders
05/09/1996WO1996013504A1 β,β'-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, BACTERIOCHLORINS, AND METHODS FOR MAKING THE SAME FROM β,β'-UNSUBSTITUTED TETRAPYRROLIC MACROCYCLES
05/09/1996WO1996013502A1 Phenyloxazolidinone antimicrobials
05/09/1996WO1996013501A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists
05/09/1996WO1996013500A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013499A1 Apolipoprotein-b synthesis inhibitors
05/09/1996WO1996013498A2 L-erythrosyl nucleosides
05/09/1996WO1996013495A1 Taxoid derivatives, their preparation and their use as antitumor agents
05/09/1996WO1996013494A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
05/09/1996WO1996013492A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
05/09/1996WO1996013491A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
05/09/1996WO1996013489A1 Process for the preparation of tetrazoles
05/09/1996WO1996013485A1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists
05/09/1996WO1996013484A1 Azetidinone derivatives for the treatment of atherosclerosis
05/09/1996WO1996013483A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996WO1996013479A1 Nitro-benzamides useful as anti-arrhythmic agents
05/09/1996WO1996013286A2 Modulation of cell proliferation and wound healing
05/09/1996WO1996013277A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013270A1 Heparin, compositions and methods of use therefore
05/09/1996WO1996013269A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996WO1996013268A2 Use of a corticosteroid to reduce the adverse effects of a perfluorochemical emulsion
05/09/1996WO1996013267A2 Combinations of prostaglandins and brimonidine or derivatives thereof for the treatment of glaucoma
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013264A1 Oral hypoglycemic agents
05/09/1996WO1996013263A2 Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
05/09/1996WO1996013262A1 Muscarine antagonists
05/09/1996WO1996013261A1 Method for treating anxiety
05/09/1996WO1996013259A2 Method and compositions for inhibiting protein kinases
05/09/1996WO1996013258A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide
05/09/1996WO1996013257A1 Use of receptor potentiators
05/09/1996WO1996013256A1 Drugs containing nitric oxide synthase inhibitors for treating immunodeficiency diseases
05/09/1996WO1996013255A1 Use of astaxanthin for retarding and ameliorating central nervous system and eye damage
1 ... 6918 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 6935 6936 6937 6938 ... 7860